Correlation Engine 2.0
Clear Search sequence regions


  • biomaterials (1)
  • bone (1)
  • bone (2)
  • calcium phosphate (7)
  • cells (3)
  • chitosan (6)
  • cryogel (4)
  • CSG1 (2)
  • electron (2)
  • flow (1)
  • fourier transform (2)
  • gauge (1)
  • male (1)
  • mice (1)
  • rats (3)
  • stems (1)
  • Sizes of these terms reflect their relevance to your search.

    The increasing interest in chitosan-based biomaterials stems from its desirable physicochemical properties. Although calcium phosphates have been mixed with chitosan to form injectable scaffolds, its application for bone tissue engineering has been limited and is still being explored to improve its clinical translatability. We report a biocomposite comprised of preformed chitosan cryogel with dispersed biphasic calcium phosphate that can flow under moderate pressure allowing passage through a small gauge needle, while maintaining sufficient integrity and strength during injection for gel recovery. The formed samples were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction analysis and protein adsorption measurements. Composite with 1% w/v biphasic calcium phosphate (CSG1) resulted in a homogeneous and rigid final structure. Injectable composite cryogel CSG1 (2.5 ± 0.2 N, 23G needle) exhibited good protein adsorption and biocompatibility. Results of subcutaneous implantation in rats reveal relatively high presence of polymorphonuclear cells but with no fibrous encapsulation with the composites, allowing further infiltration of cells within the sample implants. The biocomposite system presents a less-invasive delivery of bone filling material for stabilizing pathologic fractures. © The Author(s) 2015.

    Citation

    Celine D G Abueva, Andrew R Padalhin, Young-Ki Min, Byong-Taek Lee. Preformed chitosan cryogel-biphasic calcium phosphate: a potential injectable biocomposite for pathologic fracture. Journal of biomaterials applications. 2015 Aug;30(2):182-92

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 25805056

    View Full Text